Straumann Holding AGXSWX:STMN +1.81%99 Days Payable is 157.58 as of Dec. 2025, which is 50% above its 10-year median of 105.25. GuruFocus rates XSWX:STMN with a GF Score™ of 99/100 and a GF Value™ of CHF136.92 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Straumann Holding AG ranks better than 77.48% on this metric.
The historical rank and industry rank for Straumann Holding AG's Days Payable or its related term are showing as below:
XSWX:STMN'
s Days Payable Range Over the Past 10 Years
Min: 55.07 Med: 105.25 Max: 145.4
Current: 145.4
During the past 13 years, Straumann Holding AG's highest Days Payable was 145.40. The lowest was 55.07. And the median was 105.25.
XSWX:STMN's Days Payable is ranked better than 77.48% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs XSWX:STMN: 145.40
Straumann Holding AG's Days Payable
declined
from Dec. 2024 (172.99) to Dec. 2025 (157.58).
It may suggest that Straumann Holding AGaccelerated paying its suppliers.
Straumann Holding AG Days Payable Related Terms
Straumann Holding AG Days Payable Historical Data
* Premium members only.
The historical data trend for Straumann Holding AG's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:STMN vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Straumann Holding AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Straumann Holding AG Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's Days Payable distribution charts can be found below:
* The bar in red indicates where Straumann Holding AG's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Straumann Holding AG's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Straumann Holding AG (XSWX:STMN) has a Days Payable of 157.58 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Straumann Holding AG and its competitors. This is 50% above median its historical median of 105.25. Over the past decade, Straumann Holding AG's Days Payable has ranged from 55.07 to 145.40. According to the industry distribution chart, Straumann Holding AG ranks #179 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 22.5%.
Is Straumann Holding AG's Days Payable too high?
Straumann Holding AG's current Days Payable of 157.58 is 50% above median its 10-year median of 105.25. Over the past 10 years, this metric has ranged from a low of 55.07 to a high of 145.40. The Medical Devices & Instruments industry median Days Payable is 67.87. Straumann Holding AG's value of 157.58 is 132.2% above this industry median. Based on the distribution chart, Straumann Holding AG ranks #179 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Straumann Holding AG has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Straumann Holding AG ranks #179 out of 795 companies for Days Payable. This places Straumann Holding AG in the top 23% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.87. Straumann Holding AG's value of 157.58 is 132.2% above this benchmark. Historically, Straumann Holding AG's own Days Payable has ranged from 55.07 to 145.40 over the past decade. While the company's 10-year median is 105.25 vs. the industry median of 67.87, Straumann Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Straumann Holding AG's current Days Payable of 157.58 is 132.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Straumann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Straumann Holding AG's current Days Payable is 157.58, which is 50% above median its own 10-year median of 105.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (XSWX:STMN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF136.92, compared to a current price of CHF106.80 — trading 22% below its estimated fair value. The current Days Payable is 157.58, which is 50% above median its 10-year median of 105.25 and 132.2% above the Medical Devices & Instruments industry median of 67.87. Straumann Holding AG's overall GF Score™ is 99/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Straumann Holding AG (XSWX:STMN), the current Days Payable is 157.58 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Straumann Holding AG (XSWX:STMN) Overvalued in 2026?
Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued.
The current stock price of CHF106.80 is trading 22% below its estimated GF Value™ of CHF136.92.
GuruFocus considers Straumann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:STMN:
Days Payable: 157.58 (50% above median its 10-year median of 105.25)
GF Value™: CHF136.92 vs. price of CHF106.80 (22% below fair value)
Industry Position: 132.2% above the Medical Devices & Instruments median (#179 of 795)
No single metric tells the full story. See the XSWX:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
99GF Score
Get the complete analysis for XSWX:STMN
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:STMN has been successfully added to your 
